Published in
Elsevier, The Lancet Neurology, 3(12), p. 233-243
DOI: 10.1016/s1474-4422(13)70014-0
Links
- ORCID
- ORCID
- Elsevier
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Journal article published in 2013 by
Richard Dodel,
Axel Rominger,
Peter Bartenstein,
Frederik Barkhof,
Kaj Blennow,
Stefan Förster,
Yaroslav Winter,
Jan-Philipp Bach,
Julius Popp 
,
Judith Alferink,
Jens Wiltfang ,
Katharina Buerger,
Markus Otto,
Piero Antuono,
Michael Jacoby
and other authors.
,
Judith Alferink,
Jens Wiltfang ,
Katharina Buerger,
Markus Otto,
Piero Antuono,
Michael Jacoby
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 